“Significant milestone” for inhaled budesonide benefit as early COVID-19 therapy

Inhaled budesonide can reduce the likelihood of requiring urgent medical care for a COVID-19 infection, and can shorten recovery time as well, according to two studies. Results of the STOIC trial are now fully peer reviewed, while the larger PRINCIPLE trial has offered its first results on the treatment. “PRINCIPLE, the world’s largest platform trial ...

Already a member?

Login to keep reading.

© 2022 the limbic